Rapidly Design Multiparametrically Optimized Small Molecules with Novel Chemistry Against Hard Targets, Enhance Preclinical Target Product Profiles & Expedite Timelines from Concept to IND
Cutting-edge AI/ML-driven breakthroughs, including Monte Rosa Therapeutics’ progress in molecular glue degraders, Insilico Medicine’s recent deal with Eli Lilly, the launch of Eli Lilly's TuneLab, coupled with ongoing partnerships between Merck and Variational AI, and Pfizer and XtalPi, are fueling accelerated small molecule innovation. Biopharma are actively pursuing, and investing in, AI/ML approaches that integrate computational and medicinal chemistry insights to re-architect the small molecule discovery funnel.
The inaugural AI Convergence: Small Molecule Discovery Summit arrives at this pivotal juncture to immerse you in the applied learnings needed to catalyze the next wave of AI/ML-powered small molecule development. Delve into AI/ML applications that elucidate undruggable target protein folding, supercharge structure- and ligand-based design, leverage AI/ML-enabled virtual screening to tap into unexplored chemical space, use generative molecular design for molecular glues, covalent inhibitors and degraders, optimize ADME-T, and address data input and federated learning platform opportunities.
Unite with industry leaders such as Insilico Medicine, Psivant Therapeutics, OpenADMET, Sanofi, Novo Nordisk, as well as newcomers including Eli Lilly’s TuneLab, Expedition Medicines and Montai Therapeutics. Expect to explore AI/ML methods, use cases and the convergence of state-of-the-art AI/ML tools, alongside existing approaches, to ignite future AI/ML-enabled small molecule discovery.
This meeting uniquely brings together experts at the intersection of AI/ML, physics-based modeling, and medicinal chemistry, which is exactly where the next breakthroughs in small molecule design are happening. The agenda’s emphasis on generative modeling, structure-based drug design, and experimental validation is perfectly aligned with how we are building our platform Revenir to accelerate drug discovery
Maximilian Ebert, Executive Director, Computational Chemistry, Congruence Therapeutics, 2026 Speaker
Hanson Wade conferences boast excellent speakers and presentations on the latest science topics in a stimulating environment. I invite you to join this pivotal discussion
Alexander Hillisch, Head, Digital Molecule Discovery & Executive Director, UCB, 2026 Speaker
This conference is not only for AI/ML subject matter experts. In fact, as a non-expert in AI, I am attracted to this meeting for the possibility of bringing together top in silico, in vitro, and in vivo drug discovery experts to explore how data-driven modeling, predictive analytics, and laboratory-based innovation can reinforce each other. I look forward to discussing integrative workflows, and synergistic strategies to accelerate drug discovery
Ivan Cornella-Taracido, Chief Scientific Officer & Co-Founder, Covant Therapeutics, 2026 Speaker
Why This Summit is the ‘Best Fit’ For You:
Techbio Torchbearers
- Showcase your AI/ML methods and applications in small molecule discovery
- Benchmark against peers and learn how to achieve experimental validation
- Attract pharma, biotech, academic and open community collaborators
Pharma Adopters
- Identify potential partners and collaborators to help replenish small molecule pipelines
- Gather learnings on how to build internal AI capabilities for small molecule drug discovery
- Cut years and dollars off development cycles for small molecules from concept to IND
Biotech Innovators
- Explore a range of AI/ML methods and applications to walk away with the confidence and actionable takeaways to achieve experimental validation
- Learn how to implement AI/ML methods into your workflows and improve small molecule discovery productivity
- Establish collaborations to accelerate small molecule hit-to-lead progression
Discover the Extensive Event Agenda
- 22 World-Class AI/ML-Guided Small Molecule Discovery Speakers
- 3 Days of Exclusive Content Addressing AI/ML Methods, Applications, Tool Convergence & Confidence
- Unmatched Networking & Strategic Partnering Opportunities
- 1 Focused Industry-Lead Community of Top Techbio, Pharma & Biotech Companies
The Expert Speaker Faculty:
Look Forward to...
70+
Attendees
33%
Leading Pharma Adopters
60%
Techbio Torchbearers & Biotech Innovators
7%
Pioneering Academics & Open Community
22
World-Class Biopharma Speakers
8+
Hours of In-Person Networking
5
Interactive Discussion, Panel & Workshop Sessions
For the First Time Convene With:
Discover the 2026 Agenda
Catch the latest industry breakthroughs, emerging trends and exclusive insights through our dynamic roundtables and panel discussions.
Prioritize Partnering With Us
As the field rapidly expands, position yourself alongside leading solution providers to ensure your brand stands out as a premier choice amid growing competition.
Join Biopharma Experts
Immerse yourself in critical conversations with like-minded attendees spanning all stages of the small molecule drug discovery funnel and build invaluable connections during dedicated networking sessions.